Abstract
Covered biliary self-expandable metal stents (CSEMSs) can be partially covered (PCSEMS) or fully covered (FCSEMS) and are U.S. Food and Drug Administration approved for palliation of malignant obstruction. FCSEMSs are increasingly being used for management of benign biliary disorders because of their removability and from promising data from their use for benign biliary strictures.1,2 This has led to their use for benign biliary disorders not related to stricture, such as bile leaks, post-sphincterotomy bleeding, and perforation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
